{"id":"NCT00984204","sponsor":"Abbott Medical Devices","briefTitle":"Clinical Evaluation of Therapy™ Cool Path™ Duo Cardiac Ablation System for the Treatment of Typical Atrial Flutter (AFL)","officialTitle":"Clinical Evaluation of Therapy™ Cool Path™ Duo Cardiac Ablation System for the Treatment of Typical Atrial Flutter (AFL)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-10","primaryCompletion":"2010-08","completion":"2012-01","firstPosted":"2009-09-25","resultsPosted":"2013-12-20","lastUpdate":"2019-02-19"},"enrollment":188,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Typical Atrial Flutter"],"interventions":[{"type":"DEVICE","name":"Therapy Cool Path Duo","otherNames":[]}],"arms":[{"label":"Treatment arm","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to demonstrate that ablation with the Therapy™ Cool Path™ Duo cardiac ablation system can eliminate typical atrial flutter and that its use does not result in an unacceptable risk of serious adverse events (SAE's).","primaryOutcome":{"measure":"Primary Safety- Incidence of Intra Procedural Serious Cardiac Adverse Events Occuring Within 7 Days of Post-procedure, Regardless of Whether a Determination Can be Made Regarding Device Relatedness.","timeFrame":"7 days","effectByArm":[{"arm":"Treatment Arm","deltaMin":12,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":11},"locations":{"siteCount":22,"countries":["United States","Canada"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":12,"n":188},"commonTop":["Cardiac Arrhthymia","Palpitations"]}}